Biofortuna unveils ampDRY™ air-dried master mix

Biofortuna – the international IVD contract research and contract manufacturing company – will be launching ampDRY™, its patent pending stabilised master mix for PCR applications, at the AACC Annual Scientific Meeting and Clinical Lab
 
 
ampDRY™ air-dried master mix- small
ampDRY™ air-dried master mix- small
ST NEOTS, England - Aug. 1, 2018 - PRLog -- Biofortuna (Liverpool, UK) – the international IVD contract research and contract manufacturing company – will be launching ampDRY™, its patent pending stabilised master mix for PCR applications, at the AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago, July 29 to August 2.

ampDRY hotstart master mix has been developed to enable complete end-stage or real-time PCR assays to be stabilised in a dry format at ambient temperatures for at least 12 months, negating the requirement for cold chain shipping and storage.

ampDRY allows the straightforward creation of stabilised assays: oligonucleotides are combined with the ampDRY reagent and dispensed into PCR vessels, then stabilised by controlled air drying. Once dried, the end user simply adds their DNA sample to the stabilised reaction prior to amplification and detection. This technology offers significant benefits over other stabilisation techniques for both end users and IVD manufacturers.

ampDRY master mix is available in both bulk and small volumes, making it suitable for commercial manufacturers and laboratory use. Biofortuna also offers full IVD contract manufacturing services using ampDRY, and can customise the manufacturing process to match customer requirements and create bespoke, cost-effective stabilised products.

Biofortuna's CEO, Dr Nick Ash, commented: "We are delighted to be launching the ampDRY stabilisation master mix at AACC, complementing our world-renowned freeze-drying stabilisation service. This new technology will enable us to further support our IVD customers in the development of easy-to-use diagnostics, increasing laboratory productivity and improving quality of clinical testing and patient care."
End
Source:Biofortuna
Email:***@kdm-communications.com Email Verified
Tags:Assay Development, custom IVD manufacturing, Molecular Diagnostics
Industry:Science
Location:St Neots - Cambridgeshire - England
Subject:Products
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
kdm Communications PRs
Trending News
Most Viewed
Top Daily News

Most Viewed
Top Daily News
PTC News

Aug 01, 2018 News



Like PRLog?
9K2K1K
Click to Share